These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30741069)

  • 1. Cardiovascular events in hospitalised patients with schizophrenia: a survival analysis.
    Al-Seddik G; Hachem D; Haddad C; Hallit S; Salameh P; Nabout R; Zoghbi M
    Int J Psychiatry Clin Pract; 2019 Jun; 23(2):106-113. PubMed ID: 30741069
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular risk prediction in chronic kidney disease patients.
    Cedeño Mora S; Goicoechea M; Torres E; Verdalles Ú; Pérez de José A; Verde E; García de Vinuesa S; Luño J
    Nefrologia; 2017; 37(3):293-300. PubMed ID: 28495396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses.
    Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK
    Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2013 ACC/AHA risk score and subclinical cardiac remodeling and dysfunction: Complementary in cardiovascular disease prediction.
    Cauwenberghs N; Hedman K; Kobayashi Y; Vanassche T; Haddad F; Kuznetsova T
    Int J Cardiol; 2019 Dec; 297():67-74. PubMed ID: 31623873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient characteristics and acute cardiovascular event rates among patients with very high-risk and non-very high-risk atherosclerotic cardiovascular disease.
    Fonarow GC; Kosiborod MN; Rane PB; Nunna S; Villa G; Habib M; Arellano J; Mues KE; Sun K; Wade RL
    Clin Cardiol; 2021 Oct; 44(10):1457-1466. PubMed ID: 34351003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
    Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N
    Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study.
    Chia YC; Lim HM; Ching SM
    BMC Cardiovasc Disord; 2014 Nov; 14():163. PubMed ID: 25410585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on Cardiovascular Scoring Systems in Covid-19: Severity Correlations in Real-world Setting.
    Mozzini C; Cicco S; Setti A; Racanelli V; Vacca A; Calciano L; Pesce G; Girelli D
    Curr Probl Cardiol; 2021 May; 46(5):100819. PubMed ID: 33631706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
    Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
    HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
    Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
    Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
    Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
    HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis.
    Shen J; Lam SH; Shang Q; Wong CK; Li EK; Wong P; Kun EW; Cheng IT; Li M; Li TK; Zhu TY; Lee JJ; Chang M; Lee AP; Tam LS
    J Rheumatol; 2018 Feb; 45(2):218-226. PubMed ID: 29142027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new pooled cohort equations risk calculator.
    Preiss D; Kristensen SL
    Can J Cardiol; 2015 May; 31(5):613-9. PubMed ID: 25843167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
    Chen G; Farris MS; Cowling T; Pinto L; Rogoza RM; MacKinnon E; Champsi S; Anderson TJ
    Clin Cardiol; 2021 Nov; 44(11):1613-1620. PubMed ID: 34585767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients.
    Di Maira T; Rubin A; Puchades L; Aguilera V; Vinaixa C; Garcia M; De Maria N; Villa E; Lopez-Andujar R; San Juan F; Montalva E; Perez J; Prieto M; Berenguer M
    Liver Transpl; 2015 Jun; 21(6):812-22. PubMed ID: 27396823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
    Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the performance of three cardiovascular disease risk scores: the Estonian Biobank cohort study.
    Saar A; Läll K; Alver M; Marandi T; Ainla T; Eha J; Metspalu A; Fischer K
    J Epidemiol Community Health; 2019 Mar; 73(3):272-277. PubMed ID: 30635435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.